Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients

Immunotherapy with checkpoint inhibitors (CPIs) strongly improved the outcome of metastatic melanoma patients. However, not all the patients respond to treatment and identification of prognostic biomarkers able to select responding patients is currently of outmost importance. Considering that develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbone, Maria Luigia, Madonna, Gabriele, Capone, Alessia, Bove, Marianna, Mastroeni, Simona, Levati, Lauretta, Capone, Mariaelena, Ascierto, Paolo Antonio, De Galitiis, Federica, D’Atri, Stefania, Fortes, Cristina, Volpe, Elisabetta, Failla, Cristina Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971439/
https://www.ncbi.nlm.nih.gov/pubmed/35361879
http://dx.doi.org/10.1038/s41598-022-09373-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971439/
https://www.ncbi.nlm.nih.gov/pubmed/35361879
http://dx.doi.org/10.1038/s41598-022-09373-9

Ejemplares similares